Concepedia
Statistics
Publications
2
Citations
46
H-Index
Active since
2019
Affiliations
Nantong University(Current)
Affiliated Hospital of Nantong University
Wenli Wu is an author at Nantong University specializing in neovascularization, ophthalmology, and ocular pharmacology.
Publications per year
2019–2020
Brivanib, a multitargeted small‐molecule tyrosine kinase inhibitor, suppresses laser‐induced CNV in a mouse model of neovascular AMD
Lele Li, Manhui Zhu, Wenli Wu et al. · Journal of Cellular Physiology · 2019 · 26 citations
Medicine, Ophthalmology, Pharmacotherapy +16
Andrographolide attenuates choroidal neovascularization by inhibiting the HIF-1α/VEGF signaling pathway
Kaixuan Cui, Liu Jian, Lili Huang et al. · Biochemical and Biophysical Research Communications · 2020 · 20 citations
Life Sciences, Ophthalmology, Pharmacotherapy +14
1–2 of 2